Health Care & Life Sciences » Biotechnology | Cleveland BioLabs Inc.

Cleveland BioLabs Inc.

Cleveland BioLabs Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
11.3 M
Public Float
4.71 M
Cleveland BioLabs Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.29
Market Cap
$17.19 M
Shares Outstanding
11.3 M
Public Float
4.8 M

Profile

Address
73 High Street
Buffalo New York 14203
United States
Employees -
Website http://www.cbiolabs.com
Updated 07/08/2019
Cleveland BioLabs, Inc. is a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702.

Financials

View All

Ivan Fedyunin
Director
Lea Verny
Chairman